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Clinical background
The finding of a monoclonal immunoglobulin in the
serum defines the so-called monoclonal gammopathy.
Monoclonal components are homogeneus immunoglo-
bulins whole (intact) or fragmented, produced by a sin-
gle expanded plasma cell clone. MCs present unique
physicochemical homogeneity, which is reflected in their
immunological homogeinity. Immunological homogei-
nity by electrophoresis is shown with the appearance of
ac o m p a c tb a n dw h i c hp o s s e s s e so n l yas i n g l et y p eo f
heavy and light chains.
Protein electrophoresis is, therefore, a main method in
the laboratory of clinical chemistry in particular for the
relief and the quantification of Monoclonal Components
[1-4].
Together with the traditional techniques of electro-
phoresis on cellulose acetate or agarose gel, other analy-
tical approaches are emerging to highlight and quantify
the CM. In particular, in recent years, several authors
have emphasized the usefulness of capillary electrophor-
esis both to highlight the CM and for their quantifica-
tion [5,6].
We considered appropriate to determine, on a perso-
nal case study:
The performance of capillary electrophoresis to show
small, medium and large monoclonal components com-
paring the data obtained by this technique with those
obtained with traditional techniques, particularly with
agarose gel electrophoresis.
We performed the quantification of the CM both in
capillary electrophoresis and through conventional
densitometry.
Assessing sensibility of the two methods to show the
CM by determining the minimum detectable concentra-
tion of CM with the two methods.
Conclusions
Capillary electrophoresis has proven a reliable method
in highlighting and quantifying CM and besides involves
operational advantages such as fully automated execu-
tion, the operating speed is extremely limited and per-
formers need a lower experience. This is translated into
more reproducible constant results over time. It’s
important, however, to emphasize the need for a careful
examination of the electrophoretic paths obtained.
Often, in the presence of CM, only slight modifications
of the path are observed that could escape a careless
observer. When in doubt, immunofixation will still solve
the problem.
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